abstract |
The present invention discloses a compound of formula I, wherein A, B, R 1 , R 1a , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 all have the meanings defined in the specification of this application, and the compound is Receptor tyrosine inhibitors can be used to treat diseases and conditions related to immune cells, such as inflammation and autoimmune diseases. |